Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (1): 44-48    DOI: 10.12892/ejgo3898.2018
Original Research Previous articles | Next articles
Prevalence of pulmonary embolism in gynecological cancer: the experience of a single tertiary center in Okinawa, Japan
M. Kozaki1, T. Ooyama1, W. Kudaka1, T. Nakamoto1, A. Wakayama1, Y. Aoki1, *()
1 Departments of Obstetrics and Gynecology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To explore the incidence and outcome of pulmonary embolism (PE) cases in Japanese patients with gynecological malignancy. Materials and Methods: The authors reviewed the medical charts of all patients with gynecological malignancy who had a diagnosis of PE at this Hospital between January 2008 and December 2013. Results: Twenty patients developed PE during the study period. Nineteen patients had advanced or recurrent cancer. The incidence of PE was 1.8%, and those with ovarian, cervical, uterine corpus, and vulvar cancers were 7.5%, 0.86%, 1.0%, and 7.7%, respectively. PE developed in 12 patients before cancer treatment, six during chemotherapy, and two postoperatively. Three patients died as a result of PE. Conclusion: PE more frequently occurred in patients with ovarian and vulvar cancers, and those with advanced/recurrent disease. Patients with active gynecological cancer require thromboprophylaxis throughout hospitalization and not just in the perioperative period, and should be periodically assessed for venous thromboembolism risk.
Key words:  Pulmonary embolism      Deep vein thrombosis      Gynecological cancer     
Published:  10 February 2018     
*Corresponding Author(s):  Y. AOKI     E-mail:  yoichi@med.u-ryukyu.ac.jp

Cite this article: 

M. Kozaki, T. Ooyama, W. Kudaka, T. Nakamoto, A. Wakayama, Y. Aoki. Prevalence of pulmonary embolism in gynecological cancer: the experience of a single tertiary center in Okinawa, Japan. European Journal of Gynaecological Oncology, 2018, 39(1): 44-48.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo3898.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I1/44

[1] Zeyneb Bakacak, Mustafa Kaplanoğlu, Murat Bakacak, Tuncay çelik. Demodex folliculorum mite infestation in gynecological cancers: A case control study[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 583-586.
[2] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[3] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[4] D. Charatsi, M. Tolia, P.Vanakara, N. Tsoukalas, M. Nikolaou, D. Korfias, G. Nikolaou, A. Daponte, G. Kyrgias. Vaginal stenosis after radiation therapy for pelvic cancer: prevention and treatment options - a review of the current literature[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 185-189.
[5] S. Soeda, T. Watanabe, S. Nomura, M. Kojima, S. Furukawa, H. Endo, Z. Saze, T. Ozeki, H. Nishiyama, A. Kenjo, T. Takahashi, H. Yamada, K. Fujimori. Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 28-35.
No Suggested Reading articles found!